Multiple Myeloma: Novel Agents Robert A. Kyle, M.D. Germany June ...
Multiple Myeloma: Novel Agents Robert A. Kyle, M.D. Germany June ...
Multiple Myeloma: Novel Agents Robert A. Kyle, M.D. Germany June ...
SHOW LESS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Survival Rate<br />
N<br />
Survival Probability<br />
One-Year<br />
Two-Year<br />
% %<br />
Lenalidomide 25 mg d 1-211<br />
+ 223 88 78<br />
Dexamethasone 40 mg<br />
d 1-4, 1<br />
9-12, 9<br />
17-20<br />
vs.<br />
Lenalidomide 25 mg d 1-211<br />
+<br />
Dexamethasone 40 mg<br />
d 1, 8, 15, 22 222 96 88<br />
Rajkumar, et al., ASCO 2008
Change language